Mr Dallas John Carlson, PT | |
301 Mountain Street East, Cavalier, ND 58220-0380 | |
(701) 265-6260 | |
(701) 265-8752 |
Full Name | Mr Dallas John Carlson |
---|---|
Gender | Male |
Speciality | Physical Therapist |
Location | 301 Mountain Street East, Cavalier, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114165164 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mr Dallas John Carlson, PT P.o. Box 380, Cavalier, ND 58220-0380 Ph: (701) 265-6260 | Mr Dallas John Carlson, PT 301 Mountain Street East, Cavalier, ND 58220-0380 Ph: (701) 265-6260 |
News Archive
Basal cell carcinoma, a type of skin cancer, affects millions of people worldwide. While traditional treatment has been surgery and radiation, topical treatments in combination with surgery are showing more promise for patients with basal cell carcinoma.
In cases of severe ocular trauma involving the cornea, wound healing occurs following intervention, but at the cost of opaque scar tissue formation and damaged vision. Recent research has shown that mesenchymal stem cells (MSCs) — which can differentiate into a variety of cells, including bone, cartilage, muscle and fat cells — are capable of returning clarity to scarred corneas; however, the mechanisms by which this happens remained a mystery — until now.
An algorithm that analyses MRI images and automatically detects small changes in knee joints over time could be used in the development of new treatments for arthritis.
Currently, few antimalarial treatments exist that effectively kill liver-stage malaria parasites, which can lay dormant for months or years as in the case of Plasmodium vivax. Researchers from Kanazawa University have successfully demonstrated that administration of a baculovirus virion completely eliminates liver-stage parasites in a mouse model via BV-induced fast-acting innate immunity.
Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.
› Verified 7 days ago
Ms. Sharon A Cummings, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 313 Division S., Cavalier, ND 58220 Phone: 701-265-4789 | |
Pembina Special Education Cooperative Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 106b Division Ave., Cavalier, ND 58220 Phone: 701-265-8080 | |
Alyssa Marie Rollness, D.P.T Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 301 Mountain St E, Cavalier, ND 58220 Phone: 701-265-6260 Fax: 701-265-6358 |